In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

A new biotech is hitting the Boston scene with $50 million from Flagship Pioneering and a goal of preventing patients from ...

Some tariffs remain in place against key U.S. trading partners, but others have been postponed to give nations time to ...

Seattle, WA - NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Anumana announced that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with Boston ...

Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.

The sizable (and speedy) demand for Nintendo's Switch 2 isn't surprising. The new gaming console has been marketed as bigger and better than its predecessor of eight years past — with ...

Treasury Secretary Scott Bessent hinted that the US and South Korea could reach a trade agreement as early as next week, ...